References
- DelaloyeJCalandraTInvasive candidiasis as a cause of sepsis in the critically ill patientVirulence20145116116924157707
- HarriottMMNoverrMCImportance of Candida-bacterial polymicrobial biofilms in diseaseTrends Microbiol2011191155756321855346
- GahlotRNigamCKumarVYadavGAnupurbaSCatheter-related bloodstream infectionsInt J Crit Illn Inj Sci20144216216725024944
- MathéLVan DijckPRecent insights into Candida albicans biofilm resistance mechanismsCurr Genet201359425126423974350
- ChatterjeeSMaitiPDeyRKunduADeyRBiofilms on indwelling urologic devices: microbes and antimicrobial management prospectAnn Med Health Sci Res20144110010424669340
- MayerFLWilsonDHubeBCandida albicans pathogenicity mechanismsVirulence20134211912823302789
- TaffHTMitchellKFEdwardJAAndesDRMechanisms of Candida biofilm drug resistanceFuture Microbiol20138101325133724059922
- KuhnDMGeorgeTChandraJMukherjeePKGhannoumMAAntifungal susceptibility of Candida biofilms: unique efficacy of amphotericin B lipid formulations and echinocandinsAntimicrob Agents Chemother20024661773178012019089
- LiuSYueLGuWLiXZhangLSunSSynergistic effect of fluconazole and calcium channel blockers against resistant Candida albicansPLoS One2016113e015085926986478
- LeekhaSTerrellCLEdsonRSGeneral principles of antimicrobial therapyMayo Clin Proc201186215616721282489
- MaLKohliMSmithANanoparticles for combination drug therapyACS Nano20137119518952524274814
- FoucquierJGuedjMAnalysis of drug combinations: current methodological landscapePharmacol Res Perspect201533e0014926171228
- ChouT-CDrug combination studies and their synergy quantification using the Chou-Talalay methodCancer Res201070244044620068163
- ChouT-CTheoretical basis, experimental design, and computerized simulation of synergism and antagonism in drug combination studiesPharmacol Rev200658362168116968952
- ChangTTChouTCRational approach to the clinical protocol design for drug combinations: a reviewActa Paediatr Taiwan200041629430211198934
- BijnsdorpIVGiovannettiEPetersGJAnalysis of drug interactionsMethods Mol Biol201173142143421516426
- YadavBWennerbergKAittokallioTTangJSearching for drug synergy in complex dose-response landscapes using an interaction potency modelComput Struct Biotechnol J20151350451326949479
- DiasMFBernardes-FilhoFQuaresma-SantosMVAmorimAGSchechtmanRCAzulayDRTreatment of superficial mycoses: review. Part IIAn Bras Dermatol201388693794424474103
- GuisbiersGLaraHHMendoza-CruzRInhibition of Candida albicans biofilm by pure selenium nanoparticles synthesized by pulsed laser ablation in liquidsNanomedicine20171331095110327793789
- TinggiUSelenium: its role as antioxidant in human healthEnviron Health Prev Med200813210210819568888
- KieliszekMBłażejakSKurekEBinding and conversion of selenium in Candida utilis ATCC 9950 yeasts in bioreactor cultureMolecules2017223352
- RaoLMaYZhuangMLuoTWangYHongAChitosan-decorated selenium nanoparticles as protein carriers to improve the in vivo half-life of the peptide therapeutic BAY 55-9837 for type 2 diabetes mellitusInt J Nanomedicine201494819482825378923
- KieliszekMBłażejakSGientkaIBzducha-WróbelAAccumulation and metabolism of selenium by yeast cellsAppl Microbiol Biotechnol201599135373538226003453
- KieliszekMBłażejakSPłaczekMSpectrophotometric evaluation of selenium binding by Saccharomyces cerevisiae ATCC MYA-2200 and Candida utilis ATCC 9950 yeastJ Trace Elem Med Biol201635909627049131
- KieliszekMBłażejakSBzducha-WróbelAKurczAEffects of selenium on morphological changes in Candida utilis ATCC 9950 yeast cellsBiol Trace Elem Res2016169238739326166197
- HerreroEWellingerREYeast as a model system to study metabolic impact of selenium compoundsMicrob Cell20152513914928357286
- LetavayováLVlasákováDSpallholzJEBrozmanováJChovanecMToxicity and mutagenicity of selenium compounds in Saccharomyces cerevisiaeMutat Res2008638111017900630
- ZhaiXZhangCZhaoGStollSRenFLengXAntioxidant capacities of the selenium nanoparticles stabilized by chitosanJ Nanobiotechnology2017151428056992
- ZhangSLuoYZengHEncapsulation of selenium in chitosan nanoparticles improves selenium availability and protects cells from selenium-induced DNA damage responseJ Nutr Biochem201122121137114221292467
- PeñaASánchezNSCalahorraMEffects of chitosan on Candida albicans: conditions for its antifungal activityBiomed Res Int2013201352754923844364
- KvasničkováEPaulíčekVPaldrychováMJeždíkRMaťátkováOMasákJAspergillus fumigatus DBM 4057 biofilm formation is inhibited by chitosan, in contrast to baicalein and rhamnolipidWorld J Microbiol Biotechnol2016321118727660214
- PuYLiuAZhengYYeBIn vitro damage of Candida albicans biofilms by chitosanExp Ther Med20148392993425120626
- CheungRCFNgTBWongJHChanWYChitosan: an update on potential biomedical and pharmaceutical applicationsMar Drugs20151385156518626287217
- DaiTTanakaMHuangY-YHamblinMRChitosan preparations for wounds and burns: antimicrobial and wound-healing effectsExpert Rev Anti Infect Ther20119785787921810057
- ZhuXRadovic-MorenoAFWuJLangerRShiJNanomedicine in the management of microbial infection – overview and perspectivesNano Today20149447849825267927
- PierceCGSrinivasanAUppuluriPRamasubramanianAKLópez-RibotJLAntifungal therapy with an emphasis on biofilmsCurr Opin Pharmacol201313572673024011516
- SinghRSmithaMSSinghSPThe role of nanotechnology in combating multi-drug resistant bacteriaJ Nanosci Nanotechnol20141474745475624757944
- MonteiroDRGorupLFSilvaSSilver colloidal nanoparticles: antifungal effect against adhered cells and biofilms of Candida albicans and Candida glabrataBiofouling201127771171921756192
- SilvaSPiresPMonteiroDRThe effect of silver nanoparticles and nystatin on mixed biofilms of Candida glabrata and Candida albicans on acrylicMed Mycol201351217818422803822
- ShakibaieMSalari MohazabNAyatollahi MousaviSAAntifungal activity of selenium nanoparticles synthesized by Bacillus species Msh-1 against Aspergillus fumigatus and Candida albicansJundishapur J Microbiol201589e2638126495111
- KheradmandERafiiFYazdiMHSepahiAAShahverdiAROveisiMRThe antimicrobial effects of selenium nanoparticle-enriched probiotics and their fermented broth against Candida albicansDaru2014224824906455
- CremoniniEZonaroEDoniniMBiogenic selenium nanoparticles: characterization, antimicrobial activity and effects on human dendritic cells and fibroblastsMicrob Biotechnol20169675877127319803
- PierceCGUppuluriPTristanARA simple and reproducible 96-well plate-based method for the formation of fungal biofilms and its application to antifungal susceptibility testingNat Protoc2008391494150018772877
- PierceCGUppuluriPTummalaSLopez-RibotJLA 96 well microtiter plate-based method for monitoring formation and antifungal susceptibility testing of Candida albicans biofilmsJ Vis Exp Epub20101021
- PierceCGLopez-RibotJLCandidiasis drug discovery and development: new approaches targeting virulence for discovering and identifying new drugsExpert Opin Drug Discov2013891117112623738751
- BijnsdorpIVGiovannettiEPetersGJAnalysis of drug interactionsMethods Mol Biol201173142143421516426
- GillumAMTsayEYKirschDRIsolation of the Candida albicans gene for orotidine-5′-phosphate decarboxylase by complementation of S. cerevisiae ura3 and E. coli pyrF mutationsMol Gen Genet198419821791826394964
- SinghAYadavVPrasadRComparative lipidomics in clinical isolates of Candida albicans reveal crosstalk between mitochondria, cell wall integrity and azole resistancePLoS One201276e3981222761908
- LohbergerACosteATSanglardDDistinct roles of Candida albicans drug resistance transcription factors TAC1, MRR1, and UPC2 in virulenceEukaryot Cell201413112714224243794
- PierceCGChaturvediAKLazzellALA novel small molecule inhibitor of Candida albicans biofilm formation, filamentation and virulence with low potential for the development of resistanceNPJ Biofilms Microbiomes2015111501226691764
- VilaTVMChaturvediAKRozentalSLopez-RibotJLIn vitro activity of miltefosine against Candida albicans under planktonic and biofilm growth conditions and in vivo efficacy in a murine model of oral candidiasisAntimicrob Agents Chemother201559127611762026416861
- MatsumotoATamuraAHondaTTransfer of the species dissolved in a liquid into laser ablation plasma: an approach using emission spectroscopyJ Phys Chem2015119472650626511
- GuisbiersGWangQKhachatryanEAnti-bacterial selenium nanoparticles produced by UV/VIS/NIR pulsed nanosecond laser ablation in liquidsLaser Phys Lett201512116003
- YuBZhangYZhengWFanCChenTPositive surface charge enhances selective cellular uptake and anticancer efficacy of selenium nanoparticlesInorg Chem201251168956896322873404
- MartinezLRMihuMRTarMDemonstration of antibiofilm and antifungal efficacy of chitosan against candidal biofilms, using an in vivo central venous catheter modelJ Infect Dis201020191436144020331379
- SilesSASrinivasanAPierceCGLopez-RibotJLRamasubramanianAKHigh-throughput screening of a collection of known pharmacologically active small compounds for identification of Candida albicans biofilm inhibitorsAntimicrob Agents Chemother20135783681368723689719
- YuDKahenECubittCLIdentification of synergistic, clinically achievable, combination therapies for osteosarcomaSci Rep201551699126601688
- LaraHHRomero-UrbinaDGPierceCLopez-RibotJLArellano-JiménezMJJose-YacamanMEffect of silver nanoparticles on Candida albicans biofilms: an ultrastructural studyJ Nanobiotechnology2015139126666378
- Di VeroliGYFornariCGoldlustIAn automated fitting procedure and software for dose-response curves with multiphasic featuresSci Rep201551470126424192
- FischerERHansenBTNairVHoytFHDorwardDWScanning electron microscopyCurr Protoc Microbiol2012 Chapter 2:Unit2B.2
- KuwajimaMMendenhallJMLindseyLFHarrisKMAutomated transmission-mode scanning electron microscopy (tSEM) for large volume analysis at nanoscale resolutionPLoS One201383e5957323555711